Biomerica (BMRA) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -8,782.00 |
| Nov 30, 2025 | 1,318.00 |
| Aug 31, 2025 | 12,365.00 |
| May 31, 2025 | 4,021.00 |
| Feb 28, 2025 | -5,444.00 |
| Nov 30, 2024 | -2,567.00 |
| Aug 31, 2024 | -7,351.00 |
| May 31, 2024 | -868.00 |
| Feb 29, 2024 | -15,516.00 |
| Nov 30, 2023 | -3,683.00 |
| Aug 31, 2023 | -3,651.00 |
| May 31, 2023 | -5,347.00 |
| Feb 28, 2023 | -11,872.00 |
| Nov 30, 2022 | -6,664.00 |
| Aug 31, 2022 | -8,815.00 |
| May 31, 2022 | -5,771.00 |
| Feb 28, 2022 | 4,071.00 |
| Nov 30, 2021 | -4,579.00 |
| Aug 31, 2021 | 1,070.00 |
| May 31, 2021 | -9,571.00 |
| Feb 28, 2021 | -5,266.00 |
| Nov 30, 2020 | -7,345.00 |
| Aug 31, 2020 | -12,743.00 |
| May 31, 2020 | -12,254.00 |
| Feb 29, 2020 | -24.00 |
| Nov 30, 2019 | -2,580.00 |
| Aug 31, 2019 | -1,439.00 |
| May 31, 2019 | -8,528.00 |
| Feb 28, 2019 | -1,213.00 |
| Nov 30, 2018 | 2,968.00 |
| Aug 31, 2018 | -2,446.00 |
| May 31, 2018 | -2,599.00 |
| Feb 28, 2018 | -11,417.00 |
| Nov 30, 2017 | -1,096.00 |
| Aug 31, 2017 | -2,560.00 |
| May 31, 2017 | -2,400.00 |
| Feb 28, 2017 | -619.00 |
| Nov 30, 2016 | -1,390.00 |
| Aug 31, 2016 | -997.00 |
| May 31, 2016 | -1,958.00 |
| Feb 29, 2016 | 1,615.00 |
| Nov 30, 2015 | -4,052.00 |